About us

Our company develops diagnostic devices - laboratory tests based on principles of enzyme immunoassay, as well as real-time PCR and clinical chemistry. Extensive experience, modern equipment and a multi-level quality control system allows us to produce products that meet all international standards of laboratory diagnostics.

Products

The main activity of the company is dedicated to the development of diagnostic kits for the detection of socially significant infections: HIV, hepatitis B, C and syphilis.

HIV ½ test system is designed for simultaneous detection of antibodies to human immunodeficiency virus (HIV-½), including subtype 0 (HIV-0), as well as HIV-1 antigen p24 in human serum and plasma.

Hepatitis B test system is designed to detect the presence of surface antigen HBsAg hepatitis B virus in human serum and plasma by enzyme immunoassay (ELISA)

Hepatitis C test system for IgG and IgM antibodies detection in human serum and plasma by indirect enzyme immunoassay (ELISA)

Syphilis test system is developed to detect total antibodies to Treponema Pallidum in human serum and plasma by enzyme immunoassay (ELISA)

Laboratory

Our laboratory in Hong Kong is equipped with the latest technical innovations to achieve the best results in development and research activities.

The priority areas of research in the laboratory are:

- development of laboratory diagnostic methods for various infection diseases

- biomarker study

- creation and validation of highly sensitive test systems.